Search research articles
Contact Us
Filters
Showing results (101-110 of 108) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 108 results.
International Journal of Cancer
|
February 6, 2024
How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach
Nils Welter, Gregor Metternich, Rhoikos Furtwängler, et al.
Annals of Surgery
|
June 12, 2024
Can Lymph Node Involvement in Unilateral Wilms Tumor be Predicted by Preoperatively known Data in Combination with Intraoperative Findings?
Clemens-Magnus Meier, Rhoikos Furtwängler, Nils Welter, et al.
EJNMMI Research
|
August 12, 2025
[<sup>68</sup>Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism
Peter Kühnen, Sonal Prasad, Karin Rothe, et al.
Pediatric Blood & Cancer
|
April 29, 2026
The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor
Nils Welter, Jens-Peter Schenk, Jenny Wegert, et al.
The Journal of Pathology
|
October 4, 2023
TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants
Jenny Wegert, Anne Kristin Fischer, Balazs Palhazi, et al.
Cancers
|
February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells
Marius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2026
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study
Rhoikos Furtwängler, Rana Dandis, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 108) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 108 results.
International Journal of Cancer
|
February 6, 2024
How to improve initial diagnostic accuracy of kidney tumours in childhood?-A non-invasive approach
Nils Welter, Gregor Metternich, Rhoikos Furtwängler, et al.
Annals of Surgery
|
June 12, 2024
Can Lymph Node Involvement in Unilateral Wilms Tumor be Predicted by Preoperatively known Data in Combination with Intraoperative Findings?
Clemens-Magnus Meier, Rhoikos Furtwängler, Nils Welter, et al.
EJNMMI Research
|
August 12, 2025
[<sup>68</sup>Ga] labelled Exendin for radioguided surgery of intrapancreatic insulin producing lesions in patients with congenital hyperinsulinism
Peter Kühnen, Sonal Prasad, Karin Rothe, et al.
Pediatric Blood & Cancer
|
April 29, 2026
The Fate (Outcome) of Clinically Apparent Single Lesion and Oligofocal Nephroblastomatosis Treated According to SIOP/GPOH Protocols for Wilms Tumor
Nils Welter, Jens-Peter Schenk, Jenny Wegert, et al.
The Journal of Pathology
|
October 4, 2023
TRIM28 inactivation in epithelial nephroblastoma is frequent and often associated with predisposing TRIM28 germline variants
Jenny Wegert, Anne Kristin Fischer, Balazs Palhazi, et al.
Cancers
|
February 13, 2026
YAP1 Enhances Mesenchymal-Type Gene Expression in Human Adrenergic-Type Neuroblastoma Cells
Marius Ludwig, Kerstin Ahrens, Annika Winkler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 13, 2026
Residual Absolute Volume of Blastema as a Predictor of Clinical Outcomes in Patients With Wilms Tumor: A Report From the SIOP WT 2001 Study
Rhoikos Furtwängler, Rana Dandis, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2023
Anti-GD2 Antibody Dinutuximab Beta and Low-Dose Interleukin 2 After Haploidentical Stem-Cell Transplantation in Patients With Relapsed Neuroblastoma: A Multicenter, Phase I/II Trial
Tim Flaadt, Ruth L Ladenstein, Martin Ebinger, et al.
Page
of 11